Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NCNO vs DBD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NCNO Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

NCNO Overall Winner 6-Pillar Tally: NCNO 4 – 2 DBD Matrix Metrics: NCNO 6 – 4 DBD

As of Nov 17, 2026, nCino, Inc. (NCNO) is the stronger overall head-to-head candidate over Diebold Nixdorf, Incorporated (DBD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). NCNO carries a Unified Composite Score of 54.6/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin), whereas DBD carries 41.7/100 (SELL) at $52.38 (8.6x Forward P/E, 9.0% operating margin).

  • Technical & Structure Timing Caution: NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.1); meanwhile DBD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NCNO vs DBD
NCNO NASDAQ Head-to-Head Winner
nCino, Inc. Common Stock
Services-Prepackaged Software
$22.43
-1.51% 1D
Market Cap $2.4B
TTM Revenue $622M
Forward P/E 22.2x
Beta / 30D Vol 0.40β · 38% Vol
Unified Composite Score
54.6 / 100 HOLD
Tech 38.0 Fund 53.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 53
RSI-14: 53.1 · SMA20: $22.79 · SMA50: $21.19
DBD NYSE
Diebold Nixdorf, Incorporated
Calculating & Accounting Machines (No Electronic Computers)
$52.38
-0.93% 1D
Market Cap $1.8B
TTM Revenue $3.92B
Forward P/E 8.6x
Beta / 30D Vol 1.03β · 59% Vol
Unified Composite Score
41.7 / 100 SELL
Tech 33.0 Fund 48.0 Flow 58.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 30
RSI-14: 30.1 · SMA20: $59.52 · SMA50: $62.36

6-Pillar Scorecard Institutional Category Breakdown (NCNO 4 – 2 DBD)

Columns: Metric · NCNO · DBD
1. Valuation Multiples DBD
Forward P/E 22.2x 8.6x
Trailing P/E 71.1x 26.1x
PEG Ratio N/M N/M
EV / Revenue 4.3x 0.7x
2. Growth & Scale NCNO
Revenue Growth (YoY) +8.2% +5.2%
Earnings Growth (YoY) +147.6% -82.9%
TTM Revenue (USD) $622M $3.92B
Market Cap $2.4B $1.8B
3. Profitability & Quality DBD
Gross Margin 62.2% 26.0%
Operating Margin 8.2% 9.0%
Net Profit Margin 5.4% 2.0%
Return on Equity (ROE) 3.9% 7.7%
4. Balance Sheet & Cash Flow NCNO
Cash Generation (TTM) $132M $127M
Cash Flow Margin 21.2% 3.2%
Net Cash / Leverage $255M Net Debt (0.36x D/E) $764M Net Debt (1.01x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NCNO
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 55.7% (20th %ile) 45.7% (10th %ile)
Put/Call OI Skew 0.02x (Call-Skewed) 1.08x (Balanced)
OBV Trend / Tech Phase DISTRIBUTION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat NCNO
OpEx & R&D Intensity 54.0% of Rev ($336M) 17.0% of Rev ($667M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NCNO (6) vs DBD (4)
Institutional Metric NCNO DBD Criterion Row Edge
Market Capitalization
Scale
$2.4B $1.8B Larger Scale NCNO
Trailing P/E Ratio
Valuation
71.1x 26.1x Lower Multiple DBD
Forward P/E Ratio
Valuation
22.2x 8.6x Lower Multiple DBD
Revenue Growth (YoY)
Growth
+8.2% +5.2% Higher Growth NCNO
Operating Margin (TTM)
Profitability
8.2% 9.0% Higher Margin DBD
Net Profit Margin
Profitability
5.4% 2.0% Higher Margin NCNO
Return on Equity (ROE)
Capital Efficiency
3.9% 7.7% Higher ROE DBD
52-Week Range Position
Momentum
63% ($14–$28) 2% ($52–$92) Stronger Trend NCNO
Beta / 30D Volatility
Risk Regime
0.40β · 38% Vol 1.03β · 59% Vol Lower Realized Risk NCNO
Unified Institutional Score
Composite Signal
54.6 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite NCNO
Trailing 12M Revenue (USD)
Operating Scale
$622M $3.92B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.2% 26.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.3x EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$132M ($255M Net Debt (0.36x D/E)) $127M ($764M Net Debt (1.01x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NCNO +32.73 pp
NCNO: +10.25% · DBD: -22.48%
3M Horizon NCNO +30.74 pp
NCNO: +8.43% · DBD: -22.31%
6M Horizon NCNO +72.9 pp
NCNO: +49.07% · DBD: -23.83%
1Y Horizon NCNO +7.44 pp
NCNO: -12.09% · DBD: -19.53%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period NCNO Revenue DBD Revenue NCNO Op. Margin DBD Op. Margin Margin Leader
FY2019 N/A $4.41B N/A -0.6% DBD
FY2020 $140M $3.90B -20.4% 0.6% DBD
FY2021 $200M $3.91B -20.9% 3.5% DBD
FY2022 $270M $3.46B -26.1% -6.1% DBD
FY2023 $410M N/A -23.0% N/A NCNO
FY2024 $480M $3.75B -8.3% 4.9% DBD
FY2025 $540M $3.81B -3.4% 6.4% DBD
FY2026 $590M N/A 0.6% N/A NCNO

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NCNO CONSOLIDATION
52d in phase · OBV DISTRIBUTION
Current IV 55.7%
IV Percentile 20th %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact NCNO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DBD BREAKDOWN
79d in phase · OBV NEUTRAL
Current IV 45.7%
IV Percentile 10th %ile
Put/Call OI Skew 1.08x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DBD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NCNO Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $2.4B market capitalization and 8.2% operating margin.
OpEx & R&D Reinvestment 54.0% of Rev ($336M)
90D Engineering Disclosures 0 Published
DBD Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $1.8B market capitalization and 9.0% operating margin.
OpEx & R&D Reinvestment 17.0% of Rev ($667M)
90D Engineering Disclosures 0 Published

Investor FAQ NCNO vs DBD Key Questions & Quantitative Answers

As of Nov 17, 2026, nCino, Inc. (NCNO) is the stronger overall head-to-head candidate over Diebold Nixdorf, Incorporated (DBD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow, Options & Positioning). NCNO carries a Unified Composite Score of 54.6/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin), whereas DBD carries 41.7/100 (SELL) at $52.38 (8.6x Forward P/E, 9.0% operating margin). Technical & Structure Timing Caution: NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.1); meanwhile DBD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NCNO leads the Growth & Scale pillar: NCNO posts +8.2% YoY revenue growth and +147.6% YoY earnings growth on $622M TTM revenue (62.2% gross margin, 8.2% operating margin), compared with DBD at +5.2% YoY revenue growth and -82.9% YoY earnings growth on $3.92B TTM revenue (26.0% gross margin, 9.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), NCNO cumulative revenue shifted +321.4% while DBD shifted -13.6%. In operating R&D and SG&A reinvestment, NCNO deploys 54.0% of Rev ($336M) (0 90-day corporate R&D disclosures) versus 17.0% of Rev ($667M) (0 disclosures) for DBD.

DBD screens cheaper on headline valuation multiples. NCNO trades at 22.2x Forward P/E, 71.1x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (21.2% FCF margin), whereas DBD trades at 8.6x Forward P/E, 26.1x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (3.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NCNO (3.9% ROE) versus DBD (7.7% ROE) capital efficiency.

In options market volatility and institutional positioning, NCNO carries 55.7% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.40β · 38% Vol realized risk). By comparison, DBD carries 45.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.08x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.03β · 59% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.